{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:03:16Z","timestamp":1780030996622,"version":"3.53.1"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","award":["P30 CA138313"],"award-info":[{"award-number":["P30 CA138313"]}],"id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","award":["P30 GM103339"],"award-info":[{"award-number":["P30 GM103339"]}],"id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107070","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T15:32:51Z","timestamp":1756308771000},"page":"107070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A pathogenic alpha synuclein variant exacerbates disease progression in a neuron-specific Gba-KO mouse"],"prefix":"10.1016","volume":"215","author":[{"given":"Hannah B.D.","family":"Duffy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y. Terry","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Olmsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galina","family":"Tuymetova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney N.","family":"Pettit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances M.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard L.","family":"Proia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2025.107070_bb0005","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.cbpa.2019.10.006","article-title":"Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease","volume":"53","author":"Aerts","year":"2019","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"Pt 9","key":"10.1016\/j.nbd.2025.107070_bb0010","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awv179","article-title":"Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations","volume":"138","author":"Alcalay","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107070_bb0015","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/978-1-60761-322-0_22","article-title":"Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry","volume":"579","author":"Bielawski","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0020","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41531-022-00363-2","article-title":"Elevation of gangliosides in four brain regions from Parkinson\u2019s disease patients with a GBA mutation","volume":"8","author":"Blumenreich","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0025","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1750-3639.2008.00171.x","article-title":"Analysis of gene expression in Parkinson\u2019s disease: possible involvement of neurotrophic support and axon guidance in dopaminergic cell death","volume":"19","author":"Bossers","year":"2009","journal-title":"Brain Pathol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/10520298809107184","article-title":"Silver impregnation of Alzheimer\u2019s neurofibrillary changes counterstained for basophilic material and lipofuscin pigment","volume":"63","author":"Braak","year":"1988","journal-title":"Stain Technol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-0270(96)00121-5","article-title":"Overexpression of growth-associated proteins in the neurons of adult transgenic mice","volume":"71","author":"Caroni","year":"1997","journal-title":"J. Neurosci. Methods"},{"issue":"10","key":"10.1016\/j.nbd.2025.107070_bb0040","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/ng.3955","article-title":"A meta-analysis of genome-wide association studies identifies 17 new Parkinson\u2019s disease risk loci","volume":"49","author":"Chang","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2025.107070_bb0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13024-015-0010-2","article-title":"Selective loss of glucocerebrosidase activity in sporadic Parkinson\u2019s disease and dementia with Lewy bodies","volume":"10","author":"Chiasserini","year":"2015","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuint.2012.10.010","article-title":"Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage","volume":"62","author":"Cleeter","year":"2013","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2025.107070_bb0055","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3389\/fnins.2019.00560","article-title":"Linking the endoplasmic reticulum to Parkinson\u2019s disease and alpha-Synucleinopathy","volume":"13","author":"Colla","year":"2019","journal-title":"Front. Neurosci."},{"issue":"21","key":"10.1016\/j.nbd.2025.107070_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.179126","article-title":"Deletion of Gba in neurons, but not microglia, causes neurodegeneration in a Gaucher mouse model","volume":"9","author":"Duffy","year":"2024","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene expression omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"37","key":"10.1016\/j.nbd.2025.107070_bb0070","doi-asserted-by":"crossref","first-page":"13819","DOI":"10.1073\/pnas.0606016103","article-title":"Effective cell and gene therapy in a murine model of Gaucher disease","volume":"103","author":"Enquist","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"44","key":"10.1016\/j.nbd.2025.107070_bb0075","doi-asserted-by":"crossref","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2025.107070_bb0080","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/1873-3468.12104","article-title":"Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases","volume":"590","author":"Ferraz","year":"2016","journal-title":"FEBS Lett."},{"issue":"Pt 12","key":"10.1016\/j.nbd.2025.107070_bb0085","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1093\/brain\/awu291","article-title":"Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation","volume":"137","author":"Fishbein","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2025.107070_bb0090","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0095","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","article-title":"Alpha-Synuclein is phosphorylated in synucleinopathy lesions","volume":"4","author":"Fujiwara","year":"2002","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0100","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0065-1281(80)80019-5","article-title":"Chemical nature of the first products (nuclei) of the argyrophil staining","volume":"67","author":"Gallyas","year":"1980","journal-title":"Acta Histochem."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0105","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/BF00713531","article-title":"An immediate light microscopic response of neuronal somata, dendrites and axons to contusing concussive head injury in the rat","volume":"83","author":"Gallyas","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"5","key":"10.1016\/j.nbd.2025.107070_bb0110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/BF00310027","article-title":"Formation of \u201cdark\u201d (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis)","volume":"83","author":"Gallyas","year":"1992","journal-title":"Acta Neuropathol."},{"issue":"3","key":"10.1016\/j.nbd.2025.107070_bb0115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/ana.23614","article-title":"Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains","volume":"72","author":"Gegg","year":"2012","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.nbd.2025.107070_bb0120","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with GBA mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.nbd.2025.107070_bb0125","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1136\/jmg.2004.024455","article-title":"Parkinsonism among Gaucher disease carriers","volume":"41","author":"Goker-Alpan","year":"2004","journal-title":"J. Med. Genet."},{"issue":"5","key":"10.1016\/j.nbd.2025.107070_bb0130","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1212\/01.wnl.0000230215.41296.18","article-title":"Glucocerebrosidase mutations are an important risk factor for Lewy body disorders","volume":"67","author":"Goker-Alpan","year":"2006","journal-title":"Neurology"},{"issue":"9645","key":"10.1016\/j.nbd.2025.107070_bb0135","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0140-6736(08)61522-6","article-title":"Phenotype, diagnosis, and treatment of Gaucher\u2019s disease","volume":"372","author":"Grabowski","year":"2008","journal-title":"Lancet"},{"issue":"39","key":"10.1016\/j.nbd.2025.107070_bb0140","doi-asserted-by":"crossref","DOI":"10.3791\/1787","article-title":"A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia","author":"Guyenet","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"15","key":"10.1016\/j.nbd.2025.107070_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2118819119","article-title":"STING mediates neurodegeneration and neuroinflammation in nigrostriatal alpha-synucleinopathy","volume":"119","author":"Hinkle","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0150","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-019-0339-z","article-title":"Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson\u2019s disease","volume":"14","author":"Huebecker","year":"2019","journal-title":"Mol. Neurodegener."},{"issue":"3","key":"10.1016\/j.nbd.2025.107070_bb0155","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuroscience.2004.02.002","article-title":"Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive","volume":"125","author":"Ishida","year":"2004","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0160","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0448-18.2019","article-title":"Tmem119-EGFP and Tmem119-CreERT2 transgenic mice for labeling and manipulating microglia","volume":"6","author":"Kaiser","year":"2019","journal-title":"eNeuro"},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0165","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ana.410200208","article-title":"Type 2 and type 3 Gaucher disease: a morphological and biochemical study","volume":"20","author":"Kaye","year":"1986","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat. Methods"},{"issue":"8","key":"10.1016\/j.nbd.2025.107070_bb0175","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/brain\/awy147","article-title":"Is Parkinson\u2019s disease a lysosomal disorder?","volume":"141","author":"Klein","year":"2018","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.nbd.2025.107070_bb0180","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0185","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41531-023-00517-w","article-title":"Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson\u2019s disease","volume":"9","author":"Leyns","year":"2023","journal-title":"NPJ Parkinsons Dis."},{"issue":"7","key":"10.1016\/j.nbd.2025.107070_bb0190","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"issue":"5","key":"10.1016\/j.nbd.2025.107070_bb0195","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1073\/pnas.95.5.2503","article-title":"Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure","volume":"95","author":"Liu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.nbd.2025.107070_bb0200","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","article-title":"Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism","volume":"30","author":"Manning-Bog","year":"2009","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.nbd.2025.107070_bb0210","doi-asserted-by":"crossref","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.nbd.2025.107070_bb0215","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.nbd.2025.107070_bb0220","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaneurol.2013.1925","article-title":"A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies","volume":"70","author":"Nalls","year":"2013","journal-title":"JAMA Neurol."},{"issue":"9","key":"10.1016\/j.nbd.2025.107070_bb0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","article-title":"Occurrence of Parkinson's syndrome in type I Gaucher disease","volume":"89","author":"Neudorfer","year":"1996","journal-title":"QJM"},{"issue":"Pt 7","key":"10.1016\/j.nbd.2025.107070_bb0230","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/brain\/awp044","article-title":"Glucocerebrosidase mutations in clinical and pathologically proven Parkinson\u2019s disease","volume":"132","author":"Neumann","year":"2009","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0235","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","article-title":"Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion and anthranilic acid labeling","volume":"331","author":"Neville","year":"2004","journal-title":"Anal. Biochem."},{"issue":"3","key":"10.1016\/j.nbd.2025.107070_bb0240","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide and glucosylsphingosine (psychosine) in cerebrum and cerebellum in infantile and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.nbd.2025.107070_bb0245","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1399-0004.1985.tb00229.x","article-title":"Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants","volume":"27","author":"Nilsson","year":"1985","journal-title":"Clin. Genet."},{"issue":"10","key":"10.1016\/j.nbd.2025.107070_bb0250","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in parkinson\u2019s disease patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0255","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.1038\/s41598-024-59834-6","article-title":"An increase in ER stress and unfolded protein response in iPSCs-derived neuronal cells from neuronopathic Gaucher disease patients","volume":"14","author":"Pornsukjantra","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107070_bb0260","series-title":"Analysis of Glycosphingolipids From Animal Tissues","author":"Priestman","year":"2024"},{"issue":"12","key":"10.1016\/j.nbd.2025.107070_bb0265","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/brain\/awx285","article-title":"Excessive burden of lysosomal storage disorder gene variants in Parkinson\u2019s disease","volume":"140","author":"Robak","year":"2017","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0270","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0275","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/acn3.177","article-title":"Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease","volume":"2","author":"Rocha","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107070_bb0280","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1089\/ars.2015.6307","article-title":"Sustained systemic Glucocerebrosidase inhibition induces brain alpha-Synuclein aggregation, microglia and complement C1q activation in mice","volume":"23","author":"Rocha","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"13","key":"10.1016\/j.nbd.2025.107070_bb0285","first-page":"2645","article-title":"Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson\u2019s disease","volume":"25","author":"Rockenstein","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0290","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ng1095-170","article-title":"Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism","volume":"11","author":"Sango","year":"1995","journal-title":"Nat. Genet."},{"issue":"29","key":"10.1016\/j.nbd.2025.107070_bb0295","doi-asserted-by":"crossref","first-page":"12101","DOI":"10.1073\/pnas.1108197108","article-title":"CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy","volume":"108","author":"Sardi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020694","article-title":"Cortistatin as a novel multimodal therapy for the treatment of Parkinson\u2019s disease","volume":"25","author":"Serrano-Martinez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.nbd.2025.107070_bb0305","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"Pt 5","key":"10.1016\/j.nbd.2025.107070_bb0310","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/brain\/awu002","article-title":"Glucocerebrosidase is shaking up the synucleinopathies","volume":"137","author":"Siebert","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0315","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ymgme.2006.09.008","article-title":"Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease","volume":"90","author":"Sinclair","year":"2007","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.nbd.2025.107070_bb0320","series-title":"Bioinformatics and Computational Biology Solutions Using R and Bioconductor","first-page":"397","article-title":"Limma: linear models for microarray data","author":"Smyth","year":"2005"},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18020441","article-title":"A review of Gaucher disease pathophysiology, clinical presentation and treatments","volume":"18","author":"Stirnemann","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"40","key":"10.1016\/j.nbd.2025.107070_bb0330","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","article-title":"Glucosylsphingosine promotes alpha-Synuclein pathology in mutant GBA-associated Parkinson\u2019s disease","volume":"37","author":"Taguchi","year":"2017","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0335","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","article-title":"Gaucher disease and parkinsonism: a phenotypic and genotypic characterization","volume":"73","author":"Tayebi","year":"2001","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0340","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","article-title":"Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?","volume":"79","author":"Tayebi","year":"2003","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0345","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","article-title":"Glucocerebrosidase haploinsufficiency in A53T alpha-synuclein mice impacts disease onset and course","volume":"122","author":"Tayebi","year":"2017","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.nbd.2025.107070_bb0350","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41556-023-01339-x","article-title":"Innate immune sensing of lysosomal dysfunction drives multiple lysosomal storage disorders","volume":"26","author":"Wang","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"829","key":"10.1016\/j.nbd.2025.107070_bb0355","doi-asserted-by":"crossref","first-page":"eadk8249","DOI":"10.1126\/scisignal.adk8249","article-title":"Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice","volume":"17","author":"Wang","year":"2024","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0360","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1038\/s41467-022-32625-1","article-title":"Lysosomal exocytosis releases pathogenic alpha-synuclein species from neurons in synucleinopathy models","volume":"13","author":"Xie","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.nbd.2025.107070_bb0365","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0002-9440(10)63566-3","article-title":"Viable mouse models of acid beta-glucosidase deficiency: the defect in Gaucher disease","volume":"163","author":"Xu","year":"2003","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107070_bb0370","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ymgme.2010.12.014","article-title":"Accumulation and distribution of alpha-synuclein and ubiquitin in the CNS of Gaucher disease mouse models","volume":"102","author":"Xu","year":"2011","journal-title":"Mol. Genet. Metab."},{"issue":"21","key":"10.1016\/j.nbd.2025.107070_bb0375","doi-asserted-by":"crossref","first-page":"9975","DOI":"10.1073\/pnas.91.21.9975","article-title":"Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease","volume":"91","author":"Yamanaka","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2025.107070_bb0380","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2015.11.023","article-title":"Overexpression of alpha-synuclein simultaneously increases glutamate NMDA receptor phosphorylation and reduces glucocerebrosidase activity","volume":"611","author":"Yang","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"32","key":"10.1016\/j.nbd.2025.107070_bb0385","doi-asserted-by":"crossref","first-page":"28080","DOI":"10.1074\/jbc.M111.237859","article-title":"Alpha-synuclein interacts with Glucocerebrosidase providing a molecular link between Parkinson and Gaucher diseases","volume":"286","author":"Yap","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0390","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ymgme.2012.11.010","article-title":"Membrane-bound alpha-synuclein interacts with glucocerebrosidase and inhibits enzyme activity","volume":"108","author":"Yap","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.nbd.2025.107070_bb0395","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nn.2118","article-title":"Single-neuron labeling with inducible Cre-mediated knockout in transgenic mice","volume":"11","author":"Young","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2025.107070_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.646726","article-title":"The emerging role of neuropeptides in Parkinson\u2019s disease","volume":"13","author":"Zheng","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107070_bb0405","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","article-title":"Reversible conformational conversion of alpha-synuclein into toxic assemblies by glucosylceramide","volume":"97","author":"Zunke","year":"2018","journal-title":"Neuron"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002864?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002864?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:18:13Z","timestamp":1780028293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":81,"alternative-id":["S0969996125002864"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107070","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A pathogenic alpha synuclein variant exacerbates disease progression in a neuron-specific Gba-KO mouse","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107070"}}